BIONDVAX leads the COVID VACCINE STOCKS - up almost 14%. Vaxart down over 12%.

A relatively flat day for COVID VACCINE STOCKS with 11 up and 14 down. The average stock was down .23%. 

BiondVax was up just short of 14%. They are into Phase III trials for a universal flu shot--results due in December. 

Vaxart gave up more than 12% today after a strong performance recently.

Atara, Sorrento and BioNTech had decent days, up in the 4 to 5% range.